BOSTON (Reuters) - Six weeks before Valeant Pharmaceuticals International Inc revealed plans to reorganize and pay down debt, similar ideas to improve the drugmaker's fortunes were discussed at a private shareholder dinner attended by top investor and board member William Ackman, according to a source who participated.